Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105755095B details enzymatic synthesis of chiral hydroxy acids. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101171237B reveals a pH-controlled cyclization method yielding high-purity 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids, offering significant cost reduction in agrochemical intermediate manufacturing.
Patent CN109762768B details a novel Bacillus B8W22 strain for producing high-purity pharmaceutical intermediates with superior stereoselectivity and reduced environmental impact.
Patent CN115536720B reveals plant-based cholic acid intermediate synthesis. Eliminates animal extraction risks. Offers scalable pharmaceutical intermediates manufacturing solutions.
Patent CN113816925A reveals a high-yield Trifarotene synthesis route. Eliminating n-butyllithium enhances safety and reduces manufacturing costs for global supply chains.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Novel electrophilic substitution route for 3-hydroxymethyl-4-hydroxymandelic acid. Reduces steps, lowers cost, ensures high purity for asthma medication supply chains.
Novel water-phase synthesis route for tetrazoleacetic acid reduces waste and cost. Ideal for pharmaceutical intermediates supply chain optimization and green manufacturing compliance.
Patent CN101824438B details microbial synthesis of high-purity (S)-EHB using yeast. Offers cost-effective, scalable pharmaceutical intermediate solutions.
Novel synthesis of p-hydroxy penicillin V acid ensures high purity. Reduces costs in antibiotics manufacturing and improves supply chain reliability for global buyers.
Novel patent CN117105883B enables high-purity buffer production with reduced waste and simplified purification for pharmaceutical applications ensuring supply chain reliability.
Novel solvent-free method for Tolfenamic Acid synthesis. High yield, reduced cost, scalable production for global pharmaceutical supply chains and reliable API sourcing.
Patent CN112724107A reveals a green dehydration route for alpha-oxo-2-furyl acetic acid from 2-keto-sugar acids, offering a safer alternative for cefuroxime intermediate manufacturing.
Novel chemical resolution method for 1-R-3-fluoropiperidine-4-carboxylic acid replacing expensive chromatography with scalable Mitsunobu esterification.
Novel patent CN119504792B details mild oxidation route for edoxaban intermediate ensuring high purity and supply chain stability for pharmaceutical manufacturing partners.
Patent CN101935294B reveals diazotization deamination recycling C acid by-products, reducing waste and enhancing supply chain reliability for dye manufacturers.
Novel calcium oxide method enhances octanohydroxamic acid yield and purity. Reduces waste and cost for cosmetic ingredient manufacturing supply chains.
Novel Pd-catalyzed asymmetric synthesis for spirobarbituric acid-epoxyhexane intermediates. High yield, mild conditions, and scalable supply chain solutions for pharma.
Patent CN112279743B details a novel iridium-catalyzed asymmetric hydrogenation method for chiral alpha-amino acid esters, offering high enantioselectivity and industrial scalability for pharmaceutical intermediates.
Novel selenium-mediated cyclization for 2-benzoxazepines. High yield, mild conditions. Ideal for CNS drug intermediates. Cost-effective manufacturing solution.